Read our latest news below. Discover more about InnoCore and our technologies by selecting Downloads or Videos from the menu above. Select Events for upcoming dates and events where you can meet InnoCore.
InnoCore Pharmaceuticals joins research consortium to develop targeted drug delivery technology for more effective treatment of brain diseasesGroningen, The Netherlands – 01 December, 2024 – InnoCore Pharmaceuticals, a Dutch biopharmaceutical drug delivery...
Read more
Safeguarding the delivery of pancreatic islets for the treatment of diabetesInnoCore participated in the DRIVE consortium to develop Diabetes-Reversing Implants for enhanced Viability and long-term...
Read more
Fighting osteoarthritis! Groningen, the Netherlands, June 20, 2022 - InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...
Read more
InnoCore Pharmaceuticals to join Bill & Melinda Gates Foundation supported consortium to develop long-acting microneedle contraceptive Groningen, The Netherlands, January 15th, 2019, InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...
Read more
InnoCore Pharmaceuticals and PolyVation To Collaborate on AndroSphere™ Extended Release hCG Microspheres for Treatment of Hypogonadotropic HypogonadismGroningen, December 1, 2021 — InnoCore Pharmaceuticals, today announced that it has received funding from the European...
Read more
Innocore Pharmaceuticals Leads a Consortium to develop Microneedle-Based Influenza VaccinesGRONINGEN, The Netherlands — January 01, 2021 — Innocore Pharmaceuticals, a Dutch pharmaceutical company specializing...
Read more
InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implantGroningen, The Netherlands, September 11, 2020, InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...
Read more
Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery TechnologyGroningen, The Netherlands, July 26, 2018 – InnoCore Pharmaceuticals and Merck KGaA (operating as MilliporeSigma...
Read more
InnoCore renewed the GMP certificateGroningen, February 6th, 2018: InnoCore Pharmaceuticals renewed the GMP certificate including laboratory authorization...
Read more
InnoCore has been awarded with the "Groningen Ondernemingsprijs 2017"Groningen, 30th November 2017. With the development of long-term active medicines, InnoCore Pharmaceuticals has won the Groningen...
Read more
Exclusive License Agreement with AllerganGroningen, October 22, 2013: InnoCore Pharmaceuticals Enters into Exclusive License Agreement with Allergan Related to...
Read more